Qin-Yu Cai

1 Introduction Gestational diabetes mellitus (GDM) is one of the common pregnancy complications, affecting 6-10% of pregnant women worldwide, and is considered to be an important cause of adverse perinatal outcomes for both pregnant women and fetuses (1–3). In recent years, the prevalence of GDM has been increasing year by year and has become an important public health problem worldwide (4, 5).

1 INTRODUCTION Gestational diabetes mellitus (GDM) affects approximately 6%–10% of pregnancies and not only increases the risk of complications such as intrahepatic cholestasis of pregnancy (ICP) and infections for the expectant mother but also poses risks for the newborn, including hypoglycemia, hypocalcemia, and respiratory distress syndrome.1 Moreover, women with GDM have an increased likelihood of developing type 2 diabetes in the future.2 To reduce these complications, appropriate...

Sant-Rayn Pasricha and colleagues 1 Pasricha S-R Mwangi MN Moya E et al. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial. reported that ferric carboxymaltose is safe for treating anaemia in pregnant women in sub-Saharan Africa.